Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 287

1.

Benefit of everolimus as a monotherapy for a refractory breast cancer patient bearing multiple genetic mutations in the PI3K/AKT/mTOR signaling pathway.

Shi Y, Zhang W, Ye Y, Cheng Y, Han L, Liu P, Zhao W, Tong Z, Yu J.

Cancer Biol Med. 2018 Aug;15(3):314-321. doi: 10.20892/j.issn.2095-3941.2017.0188.

2.

Extracranial metastasis of anaplastic oligoastrocytoma.

Kang Z, Yang S, Zhang H, Zhou Q, Chen J, Li Y, Kang X, Li S, Li W.

Cancer Biol Med. 2018 Aug;15(3):311-313. doi: 10.20892/j.issn.2095-3941.2017.0181.

4.

The prognostic value of programmed cell death ligand 1 expression in non-Hodgkin lymphoma: a meta-analysis.

Zhao S, Zhang M, Zhang Y, Meng H, Wang Y, Liu Y, Jing J, Huang L, Sun M, Zhang Y, Zhang Q.

Cancer Biol Med. 2018 Aug;15(3):290-298. doi: 10.20892/j.issn.2095-3941.2018.0047.

5.

Analysis of factors related to non-sentinel lymph node metastasis in 296 sentinel lymph node-positive Chinese breast cancer patients.

Maimaitiaili A, Wu D, Liu Z, Liu H, Muyiduli X, Fan Z.

Cancer Biol Med. 2018 Aug;15(3):282-289. doi: 10.20892/j.issn.2095-3941.2018.0023.

6.

Coagulation factor VII gene polymorphisms are not associated with the occurrence or the survival of hepatocellular carcinoma: a report of 37 cases.

Lin CC, Wu CH, Chen LY, Tsai MC, Elsarawy AM, Huang KT.

Cancer Biol Med. 2018 Aug;15(3):275-281. doi: 10.20892/j.issn.2095-3941.2017.0144.

7.

Autophagic flux response and glioblastoma sensitivity to radiation.

Mitrakas AG, Kalamida D, Giatromanolaki A, Pouliliou S, Tsolou A, Kyranas R, Koukourakis MI.

Cancer Biol Med. 2018 Aug;15(3):260-274. doi: 10.20892/j.issn.2095-3941.2017.0173.

8.

Increased paracellular permeability of tumor-adjacent areas in 1,2-dimethylhydrazine-induced colon carcinogenesis in rats.

Bekusova VV, Falchuk EL, Okorokova LS, Kruglova NM, Nozdrachev AD, Markov AG.

Cancer Biol Med. 2018 Aug;15(3):251-259. doi: 10.20892/j.issn.2095-3941.2018.0016.

9.

LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214.

Chen Y, Du H, Bao L, Liu W.

Cancer Biol Med. 2018 Aug;15(3):238-250. doi: 10.20892/j.issn.2095-3941.2017.0174.

10.

Knockdown of long non-coding RNA LCPAT1 inhibits autophagy in lung cancer.

Yu X, Ye X, Lin H, Feng N, Gao S, Zhang X, Wang Y, Yu H, Deng X, Qian B.

Cancer Biol Med. 2018 Aug;15(3):228-237. doi: 10.20892/j.issn.2095-3941.2017.0150.

11.

ATM in breast and brain tumors: a comprehensive review.

Estiar MA, Mehdipour P.

Cancer Biol Med. 2018 Aug;15(3):210-227. doi: 10.20892/j.issn.2095-3941.2018.0022.

12.

New developments in immunotherapy for lymphoma.

Heyman B, Yang Y.

Cancer Biol Med. 2018 Aug;15(3):189-209. doi: 10.20892/j.issn.2095-3941.2018.0037.

13.

Ovarian cancer presenting with hypercalcemia: two cases with similar manifestations but different mechanisms.

Ma X, Wang Y, Zhang X, Dong M, Yang W, Xue F.

Cancer Biol Med. 2018 May;15(2):182-187. doi: 10.20892/j.issn.2095-3941.2018.0009.

14.

Primary resistance to crizotinib treatment in a non-small cell lung cancer patient with an EML4-ALK rearrangement: a case report.

Zhang L, Li Y, Zhang S, Gao C, Nie K, Ji Y.

Cancer Biol Med. 2018 May;15(2):178-181. doi: 10.20892/j.issn.2095-3941.2018.0003.

15.

Ultrasound features of extranodal extension in the metastatic cervical lymph nodes of papillary thyroid cancer: a case-control study.

Mu J, Liang X, Li F, Liu J, Zhang S, Tian J.

Cancer Biol Med. 2018 May;15(2):171-177. doi: 10.20892/j.issn.2095-3941.2017.0092.

16.

Diagnostic value of whole-body MRI with diffusion-weighted sequence for detection of peritoneal metastases in colorectal malignancy.

Zhang H, Dai W, Fu C, Yan X, Stemmer A, Tong T, Cai G.

Cancer Biol Med. 2018 May;15(2):165-170. doi: 10.20892/j.issn.2095-3941.2017.0162.

17.

Clinical significance of miRNA - 106a in non-small cell lung cancer patients who received cisplatin combined with gemcitabine chemotherapy.

Tian Y, Sun C, Zhang L, Pan Y.

Cancer Biol Med. 2018 May;15(2):157-164. doi: 10.20892/j.issn.2095-3941.2017.0182.

18.
19.

Progress in non-invasive detection of liver fibrosis.

Li C, Li R, Zhang W.

Cancer Biol Med. 2018 May;15(2):124-136. doi: 10.20892/j.issn.2095-3941.2018.0018.

20.

PD-1/PD-L1 pathway blockade works as an effective and practical therapy for cancer immunotherapy.

Jia L, Zhang Q, Zhang R.

Cancer Biol Med. 2018 May;15(2):116-123. doi: 10.20892/j.issn.2095-3941.2017.0086.

Supplemental Content

Loading ...
Support Center